Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses
Mater Today Bio 11, 100121
Chen PI, Cao A, Miyagawa K, Tojais NF, Hennigs JK, Li CG, et al
Finally, harmonizing the sensory experience with metabolic needs by modulating this axis emerges as a promising and transformative strategy for managing metabolic disorders in the 21st century
GLP-1 use as a potential treatment modality is limited by its short half-life in vivo due to rapid degradation by enzymes such as dipeptidyl peptidase IV (DPP-4)
Alexander Shapsis and the EndoSlim Clinic NY team to compare weight loss pills, Wegovy, GLP-1 injections, ESG, gastric balloons, and combination treatment options